Hologic Stock News

Strength in Breast Health and GYN Surgical drives Hologic's (HOLX) Q3 performance.

Hologic CEO Steve MacMillan joins 'Squawk on the Street' to discuss MacMillan's expectations for the company post-Covid, how the CEO is allocating capital, and more.

Hologic, Inc. (NASDAQ:HOLX ) Q3 2023 Earnings Conference Call July 31, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and

Although the revenue and EPS for Hologic (HOLX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street e

Hologic (HOLX) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.95 per share a year ago.

Shares of Hologic Inc. HOLX, -1.57% dropped more than 3% in the aftermarket Monday after the medical technology company topped Wall Street estimates for its fiscal third quarter and tweaked its guidan

A financial advisor can help you understand the advantages and disadvantages of investment properties.

Hologic's (HOLX) Breast Health is likely to have driven Q3 performance, owing to strong performance from improved semiconductor chip availability and strong backlog.

Diving into a world where an analyst picks stocks may feel like exploring a complex maze. These analysts, akin to dedicated scholars of the stock market, offer their expertise to investors in pointing

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2023 on Mo

Hologic continues to present with attractive business economics and robust fundamentals ex-Covid. There are additional critical factors to consider, including positive sentiment and price studies. Inv

Hologic's (HOLX) GYN Surgical business grows organically as the company registers procedural volumes return and acceleration from new business lines.

Investors are optimistic about Hologic (HOLX) on continued strength in GYN Surgical and Breast Health businesses.

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

The higher capital equipment revenues, procedural volumes return and an acceleration from the new business lines poise Hologic (HOLX) for future growth.